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Abstract: An important inorganic phase of
synthetic bone applications, calcium
hydroxyapatite (HA, Ca10(PO4)6(OH)2), was
prepared as a single-phase and sub-micron
bioceramic powder. Carbonated HA powders
were synthesized from calcium nitrate
tetrahydrate and di-ammonium hydrogen
phosphate salts dissolved in synthetic body
fluid (SBF) solutions, containing urea
(H2NCONH2) and enzyme urease, under the
biomimetic conditions of 37°C and pH 7.4,
with a novel chemical precipitation
technique. These powders were also found to
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Introduction
Calcium hydroxyapatite (HA: Ca10(PO4)6(OH)2), the
main inorganic component of human bones, is a member
of the apatite family of compounds. Biological apatites,
which comprise the mineral phases of calcified tissues
(enamel, dentin, and bone), slightly differ from pure HA
in stoichiometry, composition and crystallinity, and in
other physical and mechanical properties. They are usually
observed [1] to be carbonate-substituted and calciumdeficient.
Synthetic body fluids (SBF) prepared in accordance
with the chemical analysis of human body fluid, with ion
concentrations nearly equal to those of the inorganic
constituents of human blood plasma, were first used by
Kokubo et al. [2] to prove the similarity between the in
vitro and in vivo behavior of certain glass-ceramic
compositions. In these studies, the glass-ceramic samples
were soaked in SBF solutions, and their surfaces were
observed to be coated with a poorly crystallized calciumdeficient and carbonate-containing apatite, which was
similar to bone apatite [3].
*

contain trace amounts of Na and Mg ions in
them, intentionally incorporated by using SBF
solutions, instead of pure water, during their
synthesis. The characterization and chemical
analysis of the synthesized biomimetic HA
powders were performed by scanning
electron microscopy (SEM), powder X-ray
diffraction (XRD), Fourier-transformed infrared spectroscopy (FT-IR), and inductivelycoupled plasma atomic emission spectroscopy
(ICP-AES).

HA powders for bioceramic applications have
generally been synthesized by using aqueous solutions. It
is known [4] that calcium hydroxyapatite is the least
soluble and the most stable compound of calcium
phosphate phases in aqueous solutions at pH values
higher than 4.2. However, HA powders synthesized in
highly alkaline media [5-10] are recognized by their
relatively high thermal stability and phase purity even
after high-temperature (1,100°-1,300°C) sintering.
Chemical synthesis of HA powders in neutral and/or
slightly acidic aqueous media is known to be a more
complicated and difficult task [7, 11]. This study [12] will
focus on the determination of the experimental
parameters of HA synthesis at the physiological pH (7.4)
and temperature (37°C), in SBF solutions rich in urea and
enzyme urease.
K. de Groot et al. [8] studied the high-temperature
characteristics of synthetic HA and reported that the
synthetic HA with a Ca/P ratio near 1.67 was only stable
below 1,200°C, when sintered in a dry or wet air
atmosphere. It was claimed that beyond 1,200°C, HA
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loses its OH- groups gradually and transforms into
oxyapatite (Ca10(PO4)6O). When heated to 1,450°C,
oxyapatite was found [8] to dissociate into β-TCP,
Ca2P2O7 and Ca4P2O9. On the other hand, Taş et. al. [10]
recently reported that pure HA powders prepared in
distilled water may withstand, without decomposition,
temperatures as high as 1,300°C when heated in an air
atmosphere for 6 h.
The surface properties and synthesis conditions of
calcium hydroxyapatite, prepared by using pure water in
a highly alkaline medium, has previously been examined in
different buffers [4, 6, 13] including SBF; however, there
is no published work, to our knowledge, on the
precipitation and formation of calcium hydroxyapatite
powders in SBF solutions, containing urea and/or enzyme
urease, at 37°C and pH 7.4. The study presented here is
thus the first systematic step taken in this specific field of
biomimetic HA powder synthesis technology.
Experimental Procedure
(1) Preparation of Synthetic Body Fluid (SBF)
SBF is known to be a metastable [3] buffer solution,
and even a small, undesired variance in both of the
preparation steps and the storage temperatures may
drastically affect the phase purity and high-temperature
stability of the produced HA powders, as well as the
kinetics of the precipitation processes.
Merck (Darmstadt, Germany)-grade NaCl (99.5 %),
NaHCO3 (99.5 %), KCl (99.0 %), Na2HPO4.2H2O (99.5
%), MgCl2.6H2O (98.0 %), Na2SO4, (CH2OH)3CNH2 (99.2
%), CaCl2.2H2O (99.0 %) and HCl (37 vol%, Carlo-Erba,
Italy) were used in the preparation of the synthetic body
fluids. SBF solutions were prepared [12, 17, 18] by
dissolving appropriate quantities of the above chemicals
in de-ionized water. Reagents were added one by one
after each was completely dissolved in 700 mL of water,
in the order given in Table 1.
A total of 40 mL of 1M HCl solution was consumed
for pH adjustments during the preparation of SBF
solutions. The 15 mL aliquot of this amount was added
just before the addition of the 6th reagent, i.e.,
CaCl2.2H2O. The second portion of the HCl solution was
used in the remainder of the titration process. Following
the addition of the 8th reagent (tris(hydroxymethyl)aminomethane), the solution temperature was raised
from the ambient to 37°C. This solution was then
appropriately titrated with 1M HCl to a pH value of 7.4
at 37°C. During the titration process, the solution was
also continuously diluted with consecutive additions of deionized water to make the final volume equal to 1 L.
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(2) Synthesis of HA Powders in SBF Solutions
Stock solutions of 0.4 M Ca(NO3)2.4H2O (Riedel deHaen, 99%, Germany) and 0.16 M (NH4)2HPO4 (Merck,
99%, Germany) were used in the precipitation
experiments as the calcium and phosphate ion sources.
Urea solutions of 8 to 9.5 M were prepared (by dissolving
the urea powder in SBF) and then aged at 85°C overnight
in a sealed glass jar, to ensure the decomposition of urea.
The pH values of 9.5 M aged urea solutions were found
to be as 9.3 at 37°C, prior to their use in powder
synthesis. The enzyme urease (Merck, Lot No: 108489, 5
units/mg, Germany) was added, within a concentration
range of 2.5 to 10 units/mL, into the precipitation
solutions to establish [14] and accelerate the complete
decompositon of urea at 37°C.
Two different precipitation schemes were used during
our HA powder synthesis experiments. These two routes
are given in the flowcharts of Figures 1 and 2. The first
scheme of synthesis may be called the initial additiontype, since it involves the addition of the inorganics
(calcium nitrate and di-ammonium hydrogen phosphate)
at the beginning. The second scheme of synthesis used
was called the continuous addition-type due to the
continuous addition of a solution of the phosphate salt
into that of nitrate with a peristaltic pump.
The pH values of the solutions were maintained [12,
17] at the physiological level of 7.4 throughout the
chemical precipitation experiments. The synthesized
powders were calcined in an air atmosphere over a
temperature range of 1,100°-1,600°C for 6 to 17 hours,
following their drying at 80°C.

(3) Powder Characterization
The phase purity and the levels of crystallinity of the
calcined HA powders were studied by powder X-ray
Table 1.
Order
1
2
3
4
5
6
7
8

Chemical Composition of SBF Solutions*.
Reagent
NaCl
NaHCO3
KCl
Na2HPO4. 2H2O
MgCl2. 6H2O
CaCl2.2H2O
Na2SO4
(CH2OH)3CNH3

Amount (gpl)
6.547
2.268
0.373
0.178
0.305
0.368
0.071
6.057

* Patent Pending, Turkish Patent Institute, Turkey, Appl. No:
99/00037, January 11, 1999.
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Figure 1.
Ca(NO3)2.4H2O:
SBF solution

Urea: SBF
Solution

Process flowchart for HA
synthesis by the initial
addition scheme.

Urease

(NH4)2.HPO4
SBF solution

Mix together in a 37°C
water bath

Ultrasonic
Irradiation

Age overnight
at 37 °C & pH 7.4

Filter the precipitates
Wash 4X with H2O

Calcination:
Air, 1,100 °C, 17 h

SEM, XRD, FT-IR

Calcination:
Air, 1,100 °C, 17 h

Phase-pure HA

diffraction (Model: D-Max/B, Rigaku Co., Tokyo, Japan)
at the typical step size of 0.05° 2 θ and a count time of
1 s. A monochromated Cu-Kα tube operated at 40 kV and
20 mA was used for the generation of X-rays. All of the
collected X-ray spectra were corrected for the shifts in
the d-spacings by using pure silicon (Starck Inc.,
Germany) as an external standard. A least-squares unit
cell refinement program [15] was used for the precise
determination of crystallographic parameters of the
synthesized powders. Further details of XRD analysis are
described elsewhere [16].

Fourier-transformed infra-red spectroscopy (FT-IR)
(Model: DX-510, Nicolet Co., WI, USA) was used in the
wave number range of 4000-400 cm-1. Experimental
spectra of solid samples were obtained by preparing KBr
pellets at a 3:97 (wt%) sample-to-KBr ratio.

(4) Chemical Analysis
Inductively-coupled plasma atomic emission
spectroscopy (ICP-AES) (Model Plasma-1000, Perkin
Elmer Co., London, UK) was used for the accurate
chemical analysis of Na and Mg ions in the SBF-
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Figure 2.
Ca(NO3)2.4H2O:
SBF solution

Urea: SBF
Solution

Process flowchart for HA
synthesis by the continuous
addition scheme.

Urease

(NH4)2.HPO4
SBF solution

Mix together in a 37°C
water bath

Add slowly
w/peristaltic pump

Ultrasonic
Irradiation

Age overnight
at 37 °C & pH 7.4

Filter the precipitates
Wash 4X with H2O

Dry at 80 °C

Calcination:
Air, 1,100 °C, 17 h

SEM, XRD, FT-IR

Phase-pure HA

synthesized HA powders (after dissolution in acid
solutions) which were believed to originate from the use
of synthetic body fluids during the synthesis experiments.
Results and Discussion
Biological apatites mainly differ from the synthetically
produced calcium hydroxyapatites in terms of their
carbonate ion content (i.e., the carbonate ion levels being
incomparably lower in the latter). Body fluids may be
considered a biomimetic and plausible source for
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increasing the carbonate contents of synthetically
prepared HA bioceramics. However, the significantly low
levels of HCO3- (i.e., 27 mM) in human plasma or SBF
solutions makes it impractical for their economically
feasible use within the shorter aging times allowed in
powder synthesis technology, as compared to the aging of
natural bones of offsprings in the human body for a
typical period of about 9 months + 10 days. The pursuit
of a means of manufacturing a genuinely carbonated HA
powder mainly originated from a clinical demand for the
synthesis of an HA powder with improved in vivo

D. BAYRAKTAR, A. C. TAŞ

biocompatibility. We have hereby attempted the taking of
a first systematic step into the comparison of the
carbonate ion incorporation into the resultant
hydroxyapatite precipitates, (i) those grown in pure SBF,
and (ii) those grown in urea- and enzyme ureasecontaining SBF solutions, under the physiological
conditions of 37°C and pH 7.4.
The nominal, starting ion concentrations of the SBF
solutions used in this study [12] were matched more
closely with those of human plasma than the ones given
by Kokubo and his co-workers [2, 3]. The most
significant differences of this study, as compared to
previous works, in terms of SBF ion concentrations can
be stated as follows:

(a) the nominal, initial HCO3- ion concentration of SBF
was increased from 4.2 mM to 27.0 mM, which thus
acquired exactly the same value as that of human plasma;
(b) Cl- ion concentration was decreased from 147.8
mM to 125.0 mM in the preparation recipe, whereas the
Cl- ion concentration of human plasma is 103.0 mM.
This has been achieved [12, 17, 18] solely by
changing the 4th reagent of the SBF preparation recipe
from K-phosphate [2, 3] to Na-phosphate. The
differences between the ion concentrations of our SBF
solutions and those of human plasma are compared in
Table 2.
The as-filtered, dried and nano-sized calcium
phosphate precipitates formed at 37°C and pH 7.4 via
pure SBF (i.e., without urea) solutions have been found
[12, 17, 18] to be amorphous. Upon calcination of these
amorphous precursors in a stagnant air atmosphere at
1,100°C for 6 hours, they completely transformed into
crystalline, single-phase HA. However, it has long been a
well-confirmed experimental fact [6, 8, 10] that
synthetically prepared (via aqueous chemical precipitation
techniques) HA powders usually decompose (partially)
into tri-calcium phosphate (Ca3(PO4)2), calcium

pyrophosphate (Ca2P2O7), tetra calcium phosphate
(Ca4P2O9), and/or oxyapatite (Ca10(PO4)6O) when heated
above 1200°C in air.
The HA precipitates [12, 17, 18] formed in pure SBF
solutions had an excellent thermal stability even when
heated at 1,600°C for 6 hours in an air atmosphere.
Figure 3a shows the XRD traces of pure SBF-synthesized
HA precipitates heated at different temperatures over a
range of 1300° to 1600°C for 6 hours. The XRD spectra
of all samples were closely matched with the ICDD PDF
No: 9-432 for calcium hydroxyapatite (Ca10(PO4)6(OH)2).
HA powders of high thermal stability are expected to be
promising materials, especially for the high-temperature
requiring implant manufacturing processes, such as
plasma-spraying of ceramic powders onto metals. Figure
3b, on the other hand, shows the crystallization behavior
of initially amorphous HA precursor powders synthesized
in SBF solutions containing urea and enzyme urease.
These powders began crystallization at around 500°C
without decomposing to any other compound of the
calcium phosphate family at 1,100°C. The HA powders in
this study synthesized at 37°C, through the use of urea
and enzyme urease-containing SBF solutions, were not
calcined at temperatures higher than 1,150°C.
The biomimetic HA powders of the present study [12]
also contained trace amounts of other inorganic ions,
provided by the use of SBF solutions. ICP-AES analysis
performed on representative 1,150°C-calcined samples
indicated that these HA powders had 1,500 ppm Mg and
160 ppm Na. The powders did not contain any nitrogen,
the organic material volatilized completely during
calcination at 500°C. Na+ and Mg2+ ions, originated from
the use of SBF solutions during precipitation, were
believed to incorporate themselves in the crystal structure
of calcium hydroxyapatite. The lattice parameters of
these SBF-grown powders were measured as a = 9.417
and c = 6.876 Å. The hexagonal unit cell (of the space
group P63/m) volume was found to be equal to 527.95
Table 2.

Ion
Na+
Cl–
HCO3–
K+
Mg2+
Ca2+
HPO42–
SO42–

Kokubo, et al.[2,3](mM)

Present work (mM)

Human Plasma(mM)

142.0
147.8
4.2
5.0
1.5
2.5
1.0
0.5

142.0
125.0
27.0
5.0
1.5
2.5
1.0
0.5

142.0
103.0
27.0
5.0
1.5
2.5
1.0
0.5

Ion Concentrations of
SBF
Solutions
and
Human Plasma.
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Figure 3a.

XRD traces of HA precipitates formed in pure SBF, after heating at different temperatures (1,300°-1,600°C, 6 h, air).

Å3. The CO32- ions are known [1] to substitute, in part,
the OH- sites, and again in part the PO43- groups of the
HA structure. On the other hand, Mg2+ ions have been
claimed [1] to replace the Ca2+ sites of the HA structure.
We also believe that the Na+ ions might have placed
themselves near the OH- sites (close to the P-bonded
oxygens), and hence caused a reduction in the extent of
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de-hydroxylation at the significantly high calcination
temperatures of this study.
The FT-IR spectra of SBF-synthesized HA powders are
given in Figure 4. The top spectrum of this figure
belonged to pure SBF-grown (i.e., SBF solutions without
urea/urease) HA precipitates, after 6 hours of calcination
at 700°C in air. The CO32- ion peaks, at 2368-2361
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Figure 3b.

XRD traces of HA precipitates formed in SBF+Urea+Urease, after heating at different temperatures (90°-1,150°C, 6 h, air).

(combination of ν2 + ν3), 1467-1412 and 878 cm-1, were
clearly visible. As the calcination temperature increased,
the FT-IR peaks of the CO32- totally disappeared. The OHstretching vibration was observed at 3571 cm-1 and the
OH- bending vibration was recorded at 635 cm-1. The PO4
bands [19] were detected at 470 (ν2), 570 and 603 (ν4),
962 (ν1), 1045 and 1096 (ν3) cm-1. The bottom FT-IR

spectrum of Figure 4 was obtained from the powder
synthesis experiments that used the urea- and enzyme
urease-containing SBF solutions. The significant
qualitative presence of carbonate ions in HA structure
was again clearly apparent.
The morphology of these biomimetic HA powders
were observed by the SEM micrographs given in Figure 5.
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Figure 4.

FT-IR spectra of HA powders prepared in SBF solutions (Top: in pure SBF, Bottom: in urea- and enzyme urease-containing SBF, samples
heated at 700°C in air for 6 h).

The micrograph given in Figure 5(a) shows the submicron (with an average value of 0.25 µm) particles of
as-filtered biomimetic HA powders after drying at 90°C.
HA powders synthesized by using distilled water (instead
of SBF) had a typical particle size of 0.6-0.7 µm [10]. The
particles shown were first ultrasonically dispersed in
isopropyl alcohol (5 mg powder in 10 mL alcohol), and
then a drop of the formed dispersion was evaporated on
a clean glass substrate, prior to SEM study. The
micrograph given in Figure 5(b), on the other hand,
showed the morphology of the same powders after being
heated at 1,150°C for 12 hours, in the form of a loose
powder compact in an alumina crucible. Further
investigation of the sintering behavior of such powders
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would be important for the production of densified
bioceramic prostheses and parts. A further set of decisive
carbon analysis would, however, be required for a
quantitative determination of the amounts of CO32- ions
present in such samples.
The use of SBF solutions and the addition of enzyme
urease to SBF solutions containing urea were both
attempted for the first time in the present study for the
biomimetic synthesis of carbonated HA powders. In the
HA synthesis experiments that used the starting chemicals
Ca(NO3)2.4H2O and (NH4)2HPO4, it was known that the if
the synthesis medium was pure water, then the solution
pH values must be in the alkaline region [6-11]. On the
other hand, in the case of using SBF, the pH value needed
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Figure 5.

SEM micrographs of SBFsynthesized HA powders,
(a) 90°C, (b) 1,150°C.

A

B
for HA synthesis decreases [12, 17, 18, 20] considerably.
In combination with the initial presence of spontaneously
formed seed crystals [12, 17] in precipitation solutions,
the high ionic strength of the precipitation medium
(provided by SBF) played an important role in inducing
the formation of a pure calcium hydroxyapatite precursor
phase that would otherwise, normally, not nucleate at
such a low pH value as 7.4. Following the addition of the

enzyme urease into the precipitation solutions, the pH
values changed as shown in Figure 6. (Without the
addition of enzyme urease into the same solutions, the
plots would look like horizontal straight lines.) When the
enzyme concentration was kept at the initial, nominal
level of 2.5 units/mL, the synthesized powders consisted
of two phases, i.e., a mixture of HA (20%) and Ca3(PO4)2
(20%). However, when the enzyme concentration was

243

Biomimetic Preparation of HA Powders at 37°C in Urea-and Enzyme Urease-Containing Synthetic Body Fluids

8

Figure 6.

7.8 –
7.6 –

10 u/mL Urease

7.4 –
7.2 –

The smooth pH
control provided by
the enzyme urease
(at two different
concentrations) in
urea-containing SBF
solutions during HA
powder precipitation
at 37°C.

pH

25 u/mL Urease
7 –
6.8 –
6.6 –
6.4 –

–

–

0

–

6

–

6.2 –

30

60

90

120

125

Aging time (min)

increased to 10 units/mL, the solution pH value was
observed to rise to the vicinity of 7.4, in about the first
half hour of aging at 37°C. The powders obtained at this
concentration of urease were found to be single phase HA
after calcination at 1,100°C. The biomimetic pH control
(in the neighborhood of pH 7.4) in urea-containing
synthetic body fluids has thus been shown to be
achievable, at 37°C, by the addition of the enzyme urease
in appropriate amounts (8-10 units/mL).
Conclusions
Chemically homogeneous, single-phase calcium
hydroxyapatite (HA) powders were synthesized by a novel
chemical precipitation technique via synthetic body fluid
solutions (either pure or urea/enzyme urease-containing),

at the physiological conditions of pH 7.4 and 37°C, with
dissolved calcium nitrate tetrahydrate and di-ammonium
hydrogen phosphate salts in appropriate amounts. The
produced HA powders were shown to be carbonated and
to have unprecedented phase stability even when heated
at 1,600°C, for 6 hours, in a stagnant air atmosphere.
Biomimetic HA powders were shown to have small
amounts of other inorganic ions, provided and
incorporated into the HA structure by the SBF solutions
used during synthesis. ICP analysis performed on calcined
powders indicated that the HA powders of this study had
1500 ppm Mg and 160 ppm Na. Enzyme urease when
added in proper amounts into the urea-containing
synthetic body fluids used for HA synthesis was shown to
supply a plausible pH control required for the
achievement of biomimetic conditions.
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